Named on 2 rounds in the feed, most often at Series D+ and in Healthtech.
Rounds from 2025-09-25 to 2026-09-02
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$222M
across 2 rounds
CO-INVESTORS
11
named beside it
Named on 2 rounds in the feed, most often at Series D+ and in Healthtech.
Rounds from 2025-09-25 to 2026-09-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series E Verified against 4 of 8 sources | $125M | 2026-09-02 | [ PART ] |
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $97M | 2025-09-25 | [ PART ] |